TORONTO, July 17, 2024 /CNW/ – The Colorectal Most cancers Useful resource & Motion Community (CCRAN), a nationwide registered charity devoted to supporting, educating and advocating on behalf of colorectal most cancers sufferers and their caregivers, is proud to announce that TD Financial institution Group (TD) has renewed its funding in help of CCRAN’s revolutionary My Colorectal Most cancers Advisor program. Colorectal most cancers stays a urgent well being problem in Canada, as it’s the second main reason for cancer-related demise within the nation.
CCRAN recognized a important want for dependable, easy-to-access, evidence-based info that might assist metastatic colorectal most cancers sufferers navigate their prognosis and therapy. My Colorectal Most cancers Advisor is a biomarker-driven on-line software, designed to empower metastatic colorectal most cancers sufferers with customized details about potential therapy choices to debate with their treating oncologist. By guiding customers by a collection of questions using their pathology report, the software generates a complete, customized report outlining potential therapy choices appropriate for his or her distinctive prognosis.
The purpose is to assist sufferers have a considerate dialogue with their treating oncologist by empowering them with evidence-based info on the potential colorectal most cancers therapy choices out there. My Colorectal Most cancers Advisor was designed to encourage knowledgeable and joint decision-making between the affected person and their treating oncologist, to in the end promote a greater understanding of the affected person’s colorectal most cancers prognosis and therapy setting.
“We’re extremely grateful to TD for his or her beneficiant help,” stated Filomena Servidio-Italiano, President & CEO of CCRAN. “This funding permits us to proceed to supply and enhance upon an important useful resource that may considerably affect the lives of metastatic colorectal most cancers sufferers, giving them the information and confidence to make knowledgeable choices about their care.”
“CCRAN’s My Colorectal Most cancers Advisor not solely works to ship customized details about prognosis and therapy, but in addition helps to take away boundaries to well being schooling and help for sufferers residing with colorectal most cancers,” says Robyn Small, Senior Supervisor, Philanthropy, Sustainability & Company Citizenship, TD Financial institution Group.” By the TD Prepared Dedication, we’re proud to proceed our help for CCRAN and their efforts to enhance well being outcomes and enhance entry to equitable take care of these residing with this continual sickness.”
CCRAN’s My Colorectal Most cancers Advisor software has been instrumental in providing help and steering to numerous people throughout Canada. With TD’s monetary help, this system is poised to achieve a better variety of Canadians, offering them with the evidence-based info they should navigate their most cancers journey with competence and hope.
About CCRAN:
The Colorectal Most cancers Useful resource & Motion Community (CCRAN) is a nationwide, patient-focused advocacy group championing the well being and wellbeing of Canadians touched by colorectal most cancers and others liable to growing the illness. We offer help, schooling, and advocacy to sufferers (and their caregivers) to assist enhance sufferers’ high quality of life, in addition to their longevity.
CCRAN has lately expanded its patient-focused mandate to serve a number of tumour sort sufferers by its Well being Expertise Evaluation (HTA) affected person proof submissions, academic occasions and advocacy initiatives, to in the end scale back the burden of most cancers in Canada.
My Colorectal Most cancers Advisor might be accessed, at no cost, right here: https://www.ccran.org/my-crc-consultant.
SOURCE Colorectal Most cancers Useful resource & Motion Community (CCRAN)
For additional info on the illness, screening, and patient-focused applications CCRAN delivers throughout the nation, contact CCRAN’s Communications Coordinator, Trisha Banerjee at [email protected]
